Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making.
Acar
J
J
University of Pierre et Marie Curie, Paris, France.
Casewell
M
M
Freeman
J
J
Friis
C
C
Goossens
H
H
D000821:Animal Feed / Q000009:adverse effects; D000818:Animals; D000829:Animals, Domestic / Q000254:growth & development*; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000494:pharmacology*; D004352:Drug Resistance, Microbial / Q000235:genetics; D006020:Glycopeptides; D006801:Humans; D014769:Virginiamycin / Q000009:adverse effects / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D014769:Virginiamycin; C016249:avoparcin